OICR Official Calls for More Investment in Canadian Personalized Medicine | GenomeWeb

NEW YORK (GenomeWeb News) – Canada needs to invest in genomics research and personalized medicine in order to profit from advances in this area, according to an early release commentary article appearing online today in the Canadian Medical Association Journal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.